Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
A previous study showed that in situ MTZ vaginal gel twice daily is more effective than the
conventional vaginal gel product in sustained cure of BV( 4 weeks after treatment) (80.0% in
the in-situ gel group as compared with 47.4 in the conventional gel group.The current study
aims to compare the efficacy of the use of once daily in situ MTZ vaginal gel (0.8%) versus
twice-daily conventional MTZ vaginal gel in treatment of BV.